Novel Beta Lactam Antibiotics for the Treatment of Multidrug-Resistant Gram-Negative Infections in Children: A Narrative Review

Infections due to carbapenem-resistant Enterobacterales (CRE) are increasingly prevalent in children and are associated with poor clinical outcomes, especially in critically ill patients. Novel beta lactam antibiotics, including ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Venuti, Francesco, Romani, Lorenza, De Luca, Maia, Tripiciano, Costanza, Palma, Paolo, Chiriaco, Maria, Finocchi, Andrea, Lancella, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385558/
https://www.ncbi.nlm.nih.gov/pubmed/37512970
http://dx.doi.org/10.3390/microorganisms11071798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385558/
https://www.ncbi.nlm.nih.gov/pubmed/37512970
http://dx.doi.org/10.3390/microorganisms11071798

Ejemplares similares